X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare PLETHICO PHARMA with Unichem Lab - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PLETHICO PHARMA vs UNICHEM LAB - Comparison Results

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    PLETHICO PHARMA UNICHEM LAB PLETHICO PHARMA/
UNICHEM LAB
 
P/E (TTM) x -1.1 22.4 - View Chart
P/BV x 0.0 2.4 0.7% View Chart
Dividend Yield % 0.0 0.8 -  

Financials

 PLETHICO PHARMA   UNICHEM LAB
EQUITY SHARE DATA
    PLETHICO PHARMA
Mar-14
UNICHEM LAB
Mar-16
PLETHICO PHARMA/
UNICHEM LAB
5-Yr Chart
Click to enlarge
High Rs395334 118.2%   
Low Rs31174 18.0%   
Sales per share (Unadj.) Rs604.4146.9 411.4%  
Earnings per share (Unadj.) Rs32.511.9 273.1%  
Cash flow per share (Unadj.) Rs51.316.2 317.1%  
Dividends per share (Unadj.) Rs02.00 0.0%  
Dividend yield (eoy) %00.8 0.0%  
Book value per share (Unadj.) Rs473.6105.1 450.5%  
Shares outstanding (eoy) m34.0890.84 37.5%   
Bonus/Rights/Conversions -ESOP-  
Price / Sales ratio x0.41.7 20.4%   
Avg P/E ratio x6.621.4 30.7%  
P/CF ratio (eoy) x4.215.7 26.5%  
Price / Book Value ratio x0.52.4 18.6%  
Dividend payout %016.8 0.0%   
Avg Mkt Cap Rs m7,26223,073 31.5%   
No. of employees `000NA5.7 0.0%   
Total wages/salary Rs m1,5962,558 62.4%   
Avg. sales/employee Rs ThNM2,352.5-  
Avg. wages/employee Rs ThNM450.9-  
Avg. net profit/employee Rs ThNM190.4-  
INCOME DATA
Net Sales Rs m20,59813,346 154.3%  
Other income Rs m386192 201.3%   
Total revenues Rs m20,98413,538 155.0%   
Gross profit Rs m2,8181,639 171.9%  
Depreciation Rs m642390 164.7%   
Interest Rs m1,59329 5,531.9%   
Profit before tax Rs m9691,412 68.6%   
Minority Interest Rs m00-   
Prior Period Items Rs m0-4 0.0%   
Extraordinary Inc (Exp) Rs m0-35 0.0%   
Tax Rs m-138293 -47.3%   
Profit after tax Rs m1,1071,080 102.5%  
Gross profit margin %13.712.3 111.4%  
Effective tax rate %-14.320.7 -68.9%   
Net profit margin %5.48.1 66.4%  
BALANCE SHEET DATA
Current assets Rs m18,8775,979 315.7%   
Current liabilities Rs m11,8962,432 489.2%   
Net working cap to sales %33.926.6 127.5%  
Current ratio x1.62.5 64.5%  
Inventory Days Days3663 57.0%  
Debtors Days Days19860 327.7%  
Net fixed assets Rs m9,8616,403 154.0%   
Share capital Rs m341182 187.5%   
"Free" reserves Rs m12,3319,293 132.7%   
Net worth Rs m16,1399,548 169.0%   
Long term debt Rs m4,706230 2,042.4%   
Total assets Rs m33,14612,843 258.1%  
Interest coverage x1.650.0 3.2%   
Debt to equity ratio x0.30 1,208.4%  
Sales to assets ratio x0.61.0 59.8%   
Return on assets %8.18.6 94.3%  
Return on equity %6.911.3 60.6%  
Return on capital %12.314.3 85.7%  
Exports to sales %21.429.2 73.1%   
Imports to sales %15.26.3 240.0%   
Exports (fob) Rs m4,4023,900 112.9%   
Imports (cif) Rs m3,136847 370.4%   
Fx inflow Rs m4,4024,356 101.1%   
Fx outflow Rs m3,1841,162 273.9%   
Net fx Rs m1,2193,194 38.1%   
CASH FLOW
From Operations Rs m2,4371,119 217.8%  
From Investments Rs m-6,265-853 734.2%  
From Financial Activity Rs m2,490-334 -745.1%  
Net Cashflow Rs m-1,337-68 1,957.8%  

Share Holding

Indian Promoters % 82.7 50.1 165.1%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 4.3 15.1 28.5%  
FIIs % 5.5 3.0 183.3%  
ADR/GDR % 0.0 0.0 -  
Free float % 7.5 31.7 23.7%  
Shareholders   10,665 20,176 52.9%  
Pledged promoter(s) holding % 85.7 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare PLETHICO PHARMA With:   FDC LTD.  ALEMBIC LTD  WYETH LTD  AJANTA PHARMA  SUVEN LIFE  

Compare PLETHICO PHARMA With:   ACTAVIS (US)  MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Global Markets Remain Volatile Ahead of US Growth Concerns(RoundUp)

Benchmark indices in US corrected marginally by 0.8% during the week. Minutes of Federal Reserve's July meeting are out and the situation looks to be in favor of the emerging markets.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

Demonetisation Barely Made Any Difference to Tax Collections(Vivek Kaul's Diary)

Aug 7, 2017

The data tells us quite a different story from the one the government is trying to project.

A 'Backdoor' to Multibaggers: It's Like Investing in Asian Paints Ten Years Ago(The 5 Minute Wrapup)

Aug 10, 2017

Don't miss these proxy bets on growing companies or in a few years you will be looking back with regret.

Should You Invest In Bharat-22 ETF? Know Here...(Outside View)

Aug 8, 2017

Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

7 Financial Gifts For Your Sister This Raksha Bandhan(Outside View)

Aug 7, 2017

Raksha Bandhan signifies the brother-sister bond. Here are 7 thoughtful financial gifts for sisters...

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

PLETHICO PHARMA SHARE PRICE


Jun 13, 2016 (Close)

TRACK PLETHICO PHARMA

  • Track your investment in PLETHICO PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON PLETHICO PHARMA

PLETHICO PHARMA 8-QTR ANALYSIS

COMPARE PLETHICO PHARMA WITH

MARKET STATS